Skip to main content

Eli Lilly shares jump after company says it's seeking FDA clearance for antibody drug

Shares of Eli Lilly rose on Wednesday after the company announced it submitted a request the U.S. FDA for emergency authorization of its Covid-19 antibody treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.